Core Insights - Penelope Bourbon has partnered with FCancer to launch two limited-edition whiskey blends, aiming to raise over $500,000 for cancer support initiatives [1][2][3] - The collaboration emphasizes community involvement and aims to honor those affected by cancer while promoting awareness and support [2][3][5] Company Overview - Penelope Bourbon is recognized as one of the fastest-growing premium whiskey brands, established in 2018, and has received multiple industry awards for its products [7] - FCancer is a nonprofit organization focused on advancing health equity through cancer prevention, early detection, and support programs [7][9] Product Details - The FCancer blend will be bottled at 94 proof (47% ABV) with a suggested retail price of $79.99 per 750ml, while the FCancer Barrel Strength will be at 114.6 proof (57.3% ABV) priced at $99.99 per 750ml [5] - The FCancer blend features a complex flavor profile including aromas of black pepper, caramel, and citrus zest, while the Barrel Strength blend offers notes of sweet cream and baking spices [4][5] Fundraising Events - A live fundraising event is scheduled for October 29, 2025, in Austin, Texas, with ticket sales contributing directly to FCancer's mission [6] - The event marks the first live fundraising initiative for the partnership, reinforcing the commitment to community support and awareness [6]